GSK3B and liver disorder: At the mechanistic level, this study suggests that SRC family kinases may regulate the immune microenvironment through non-ATP-competitive binding, while the ADRB2-GSK3B axis may participate in the interplay between metabolism and inflammation, providing potential targets for modulating the immunometabolic network in liver disease.